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Abstract
Background: Signaling by the Wnt family of secreted glycoproteins through their receptors, the
frizzled (Fz) family of seven-pass transmembrane proteins, is critical for numerous cell fate and
tissue polarity decisions during development.
Results: We report a novel role of Wnt signaling in organogenesis using the formation of the islet
during pancreatic development as a model tissue. We used the advantages of the zebrafish to
visualize and document this process in living embryos and demonstrated that insulin-positive cells
actively migrate to form an islet. We used morpholinos (MOs), sequence-specific translational
inhibitors, and time-lapse imaging analysis to show that the Wnt-5 ligand and the Fz-2 receptor are
required for proper insulin-cell migration in zebrafish. Histological analyses of islets in Wnt5a-/-
mouse embryos showed that Wnt5a signaling is also critical for murine pancreatic insulin-cell
migration.
Conclusion: Our results implicate a conserved role of a Wnt5/Fz2 signaling pathway in islet
formation during pancreatic development. This study opens the door for further investigation into
a role of Wnt signaling in vertebrate organ development and disease.
Background
Wnt signaling pathways play important roles in both nor-
mal development and in the pathogenesis of a variety of
diseases, including cancer [1]. Activation of a Wnt signal-
ing pathway requires interaction between a secreted glyc-
oprotein, Wnt, and a seven-pass transmembrane receptor
protein, Frizzled (Fz). Different combinations of Wnt and
Fz ligand-receptor pairs can transduce at least three dis-
tinct kinds of intracellular signaling pathways. The
"canonical" Wnt signaling pathway (Wnt/β-catenin path-
way) results in changes of intracellular β-catenin levels
and is thought to be involved in cell fate specification and
proliferation. Wnt pathway activation can also lead to
changes in either intracellular Ca2+ concentration (Wnt/
Ca2+ pathway) or actin cytoskeleton reorganization (Wnt/
tissue polarity pathway) [2]. The role(s) of these 'non-
canonical' Wnt signaling pathway(s) in organ formation
are largely unknown.
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A function for Wnt signaling has been suggested by the
expression patterns of Wnt and Fz genes during develop-
ment of the mouse embryonic pancreas [3]. At embryonic
day E11, Wnt5a  and  Fz-2 are expressed in the mesen-
chyme and epithelium of the pancreas. At E17.5, both
Wnt5a and Fz-2 are co-localized with insulin- and gluca-
gon-expressing cells. In contrast, only Wnt5a is expressed
in the surrounding mesenchyme. In situ hybridization and
RT-PCR gene expression analysis showed that both Wnt5a
and Fz-2 are expressed in the embryonic pancreas from
E11 until the end of gestation as well as postnatally. The
highest level of expression is at E12 for Wnt5a, and at E12-
E13 for Fz-2. Overexpression of Wnt5a in the pancreas
results in the formation of multiple small and scattered
islets, but the mechanism for such abnormality has not
been characterized [3].
We explored a role of Wnt signaling in insulin-positive cell
migration to form a pancreatic islet. In the mouse embryo
at about E9.5, the primitive pancreatic epithelial cells
express a transcription factor, pdx-1.  Glucagon-positive
cells are first detected around E10.5, and insulin-positive
cells around E11.5 within the pancreatic ductal epithe-
lium [4]. At E15.5, clusters of intermingled insulin-posi-
tive and glucagon-positive cells are found in the pancreatic
interstitium, largely associated with the ducts [4,5]. Dur-
ing the last 4 days of gestation and postnatally, endocrine
cells detach from the ducts, increase in number, and, at
E17.5-E18.5, reorganize to form mature islets with the
core of insulin-expressing cells surrounded by glucagon-
expressing cells [6]. Formation of mature islets is thought
to require migration of endocrine cells out of the pancre-
atic ductal epithelium to the pancreatic mesenchyme.
These processes are partially controlled by matrix metallo-
proteinases (MMPs), a family of enzymes that degrade
extracellular matrix proteins [7]. TGF-β signaling is neces-
sary for the activation of MMP-2, which affects islet mor-
phogenesis in vitro [8]. Recently, it has been reported that
EGF signaling also regulates activation of MMP-2 and
affects insulin-positive cell migration [6]. In mice lacking
EGF-receptors, the majority of insulin-positive cells
remain associated with pancreatic ducts in the newborn
period.
The zebrafish pancreas functions similarly to that of other
vertebrates by secreting hormones and exocrine enzymes
to regulate blood glucose level and participate in diges-
tion, respectively [9,10]. As in other vertebrates, synthesis
and secretion of endocrine hormones in zebrafish occur
in an islet called the Brockmann body, but unlike other
vertebrates, only a single islet initially forms [11]. Thus,
the zebrafish islet provides a model for the simplest endo-
crine pancreas with the core biological complexity of
other vertebrates. Insulin-positive cells are specified as
bilateral patches around the 14-somite stage and subse-
quently form a single islet in the midline [12]. Immuno-
histochemical studies using antibodies against insulin
and glucagon revealed that the zebrafish islet consists of a
core of insulin-expressing cells surrounded by glucagon-
expressing cells, a structural organization similar to that
observed in the mouse and the human [11,12]. However,
the pattern of cell migration and the molecular mecha-
nisms of zebrafish islet morphogenesis have not been pre-
viously investigated.
We characterized the process of insulin-positive cell migra-
tion in zebrafish and examined a role of Wnt signaling in
pancreatic islet formation in zebrafish and the mouse. We
show that wnt-5/fz-2 signaling is required for proper islet
formation in zebrafish, and we demonstrate that Wnt5a
signaling is required for the separation of islets from the
ducts in the mouse. These phenotypes in zebrafish and
mouse are consistent with defects in insulin-positive cell
migration demonstrating a new and conserved role of
Wnt signaling in vertebrate endocrine pancreas forma-
tion.
Results
Loss of direction results in scattered insulin-positive cells in 
embryos injected with fz-2 morpholinos
To study the function of fz-2, we used morpholino-modi-
fied oligonucleotides (MOs) as sequence-specific transla-
tional inhibitors in zebrafish [13]. Injection of fz-2 MOs
[14] into transgenic zebrafish embryos ('morphants') car-
rying the GFP reporter gene under the control of the insu-
lin promotor (insulin:GFP transgenic fish: [15]) resulted
in scattered GFP-positive cells compared to the single islet
observed in wild-type (WT) embryos (Fig. 1A,B). To deter-
mine the cause of abnormal insulin expression in FZ-2
morphants, we conducted a time-lapse imaging analysis.
In wild-type embryos, bilateral insulin-positive cells first
appeared at approximately the 14-somite stage. These
cells divided and actively migrated to the posterior. As
insulin-positive cells migrate, these cells converge in the
midline. By the 24 hours-post-fertilization (hpf) stage, all
insulin-positive cells associate to form a single islet at the
midline (Fig. 1C–H [also see additional file 1]). We have
also performed a time-lapse analysis on insulin:GFP trans-
genic embryos injected with rhodamine-conjugated dex-
tran (Molecular Probe, D-1841). This created embryos
with GFP expression in the insulin-positive cells and
rhodamine localized to random cells in a mosaic pattern.
We found that the GFP-negative cells labeled with rhod-
amine did not change their relative positions and did not
show any morphological changes associated with migrat-
ing cells, while GFP-positive cells moved posteriorly and
medially, arguing that the GFP positive cells move relative
to their neighboring cells [see additional file 2]. Plotting
the trajectory of GFP-positive cells demonstrated that the
pattern of cell migration is mostly along a straight lineBMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
Page 3 of 21
(page number not for citation purposes)
Time-lapse imaging of insulin:GFP transgenic embryos shows cell migration defects in Fz-2 morphants Figure 1
Time-lapse imaging of insulin:GFP transgenic embryos shows cell migration defects in Fz-2 morphants. (A, C-H) 
Uninjected insulin:GFP transgenic embryo, (B, I-N) fz-2 MO-injected insulin:GFP transgenic embryo. All panels are dorsal views 
and anterior is to the left. Scale bar represents 100 µm. (A) Uninjected transgenic embryo, 24 hpf. (B) Fz-2 MO-injected trans-
genic embryo, 24 hpf. (C) At the 14-somite stage, bilateral patches of GFP-positive cells are visible in uninjected embryo. (D) 
At the 15–16 somite stage, GFP-positive cells have started proliferating. (E-G) At the 17 somite to 24 hpf stages, GFP-positive 
cells are aligned in bilateral rows of cells and undergo a medial and posterior migration. (H) At 24 hpf, all GFP-positive cells 
have merged to form one islet. (I) At the 14-somite stage, bilateral patches of GFP expression are apparent in fz-2 MO-injected 
embryos similar to uninjected embryos. (J-M) GFP-positive cells migrate in random directions in fz-2 morphant embryos. (N) 
At 24 hpf, GFP-positive cells have still not merged. (O) Trajectory of GFP-positive cells in uninjected insulin:GFP embryo. 
Notice that cells are uniformly moving posteriorly. (P) Trajectory of GFP-positive cells in fz-2 MO-injected insulin:GFP embryo. 
Notice cells are moving in random directions. A: anterior, P: posterior, T: time, L: left, R: right, O: origin.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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from the initial to the final position (Fig. 1O). The average
migration rate of a GFP positive cell was 0.3 ± 0.12 µm/
minute and average A-P progression was 0.3 ± 0.04 µm/
minute (n = 10).
In transgenic insulin:GFP zebrafish embryos injected with
fz-2 MO, bilateral insulin-positive cells also appeared at
the 14-somite stage, as observed in uninjected transgenic
embryos. However, these cells failed to migrate to the pos-
terior. At 24 hpf, insulin-positive cells remained scattered
in fz-2 morphants (Fig. 1I–N [also see additional file 3]).
The average migration rate of a GFP-positive cell was 0.3
± 0.08 µm/minute, similar to uninjected transgenic
embryos, indicating that the GFP-positive cells are capable
Migration defects in Fz-2 morphant embryos can be rescued by synthetic fz-2 mRNA Figure 2
Migration defects in Fz-2 morphant embryos can be rescued by synthetic fz-2 mRNA. (A) Double in situ hybridiza-
tion with fz-2 and insulin at 20 somite stage of development. Arrow, insulin; arrowhead, fz-2 expression in the endoderm; dot-
ted line, approximate position of the section in (B). (B) A section of double in situ hybridization with fz-2 and insulin. Fz-2 is 
expressed more strongly on the surface of mesoderm and entire endoderm. Arrow, insulin; arrowhead, fz-2 expression in the 
endoderm; a, arteries; asterisk, neural tube; d, pronephric duct. (C) RT-PCR using cDNA made from sorted cells of transgenic 
insulin:GFP zebrafish embryos. L: ladder; lanes 1–5: GFP-negative cells; lanes 6–10: GFP-positive cells; lanes 1, 6: EF1α lanes2, 7: 
insulin; lanes 3, 8: fz-2 primer set #1; lanes 4, 9: fz-2 primer set #2; lanes 5, 10: wnt-5. (D) High-dose injection of either fz-2 
MO1 or MO2 resulted in scattered insulin expression, whereas low dose injection of either MO caused such defects in less 
than 10% of embryos. Co-injection of low dose fz-2 MO1 and MO2 resulted in synergistic increase of percentage of embryos 
with scattered insulin expression. (E) 80% of fz-2 MO-injected embryos displayed scattered insulin expression. Co-injection of 
fz-2 MO and fz-2 RNA reduced the percentage of embryos with abnormal insulin expression down to 45%. (F-I) In situ hybridi-
zation with insulin at 24 hpf stage, anterior is to the left, (F) fz-2 MO1-injected embryo, (G) fz-2 mismatch MO-injected embryo, 
(H) fz-2 RNA-injected embryo, (I) fz-2 MO- and fz-2 RNA-co-injected embryo. Notice the compact islet in this embryo that 
displays an undulated notochord.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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of moving at the normal speed. However, the trajectory of
insulin-positive cells in fz-2 MO-injected embryos showed
that the cells were moving randomly (Fig. 1P). The aver-
age A-P progression of an insulin-expressing cell in fz-2
morphant embryos was -0.02 ± 0.07 µm/minute (n = 10).
These data argue that GFP-positive cells still can move
normally but have lost directional information in fz-2
MO-injected transgenic embryos.
Fz-2 and insulin are expressed in neighboring cells
As we reported earlier, fz-2 is restricted to somitic meso-
derm and posterior paraxial mesoderm starting at the one
somite stage. This expression pattern remains similar dur-
ing somitogenesis, although the expression level of fz-2 in
somitic mesoderm gradually decreases after 12–14 somite
stage. (Fig. 2A, [14]). Double in situ hybridization of insu-
lin  and  fz-2  and subsequent sectioning of the embryo
Wnt-5 has a specific role in islet formation Figure 3
Wnt-5 has a specific role in islet formation. (A) Double in situ hybridization with pdx-1 and wnt-5, 10 som stage, dorsal 
view, the anterior is to the left. Arrow, pdx-1 expression, bracket, wnt-5 expression. (B-H) In situ hybridization with insulin at 
24 hpf. (B) wild-type, (C) WNT-8 morphant embryos, (D) WNT-11 morphant embryos, (E) WNT-5 morphant embryos, 
(F)wnt-5 mismatch MO-injected embryos, (G) wnt-5 RNA injected embryo, (H) wnt-5 MO and wnt-5 RNA co-injected embryo. 
Notice the compact islet in this embryo that displays an undulated notochord. (I) Percentage of embryos with scattered insulin 
expression resulting from injection of wnt-5 MO reduced significantly from 60% to 10% when wnt-5 RNA was co-injected with 
wnt-5 MO. (J-L) Morphology at 24 hpf, (J) wild-type, (K) wnt-5 insertional mutant, (L) wnt-5 translation-blocking MO-injected 
embryos. Notice that wnt-5 MO injected embryos have more severe morphological phenotype than wnt-5 insertional mutant 
embryos. (M) RT-PCR analysis of wnt-5 transcript in wnt-5 exon-intron MO injected embryos. Injection of wnt-5 exon-intron 
MO results in severely shortened wnt-5 transcript. L:ladder, 1:EF-1α control, 2:wnt-5.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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showed that fz-2 expression is concentrated on the surface
of somatic mesoderm and the entire endoderm adjacent
to insulin-expressing cells (Fig. 2A,B). To determine if fz-2
is expressed in the insulin-positive cells, we sorted GFP-
positive and -negative cells from the 20 somite stage insu-
lin:GFP trangenic zebrafish embryos using Fluorescent
Automated Cell Sorting (FACS), isolated total RNA from
each sample, synthesized cDNA, and performed RT-PCR
analysis for the presence of fz-2 transcript in the GFP-pos-
itive cells. As expected, EF-1α, a positive control, but not
insulin was detected in the GFP-negative cells (Fig. 2C). In
contrast, both EF1-α and insulin transcripts were detected
in GFP-positive sample (Fig. 2C) indicating that the cell
sorting procedure was effective. Two different sets of prim-
ers designed to amplify fz-2 transcripts produced bands
from the GFP-negative cells but not from the GFP-positive
cells (Fig. 2C). Our analysis shows that even though fz-2
and insulin are expressed in neighboring cells as detected
by in situ hybridization, they are not co-expressed in the
same cells.
Fz-2 plays a specific role in pancreatic islet formation
To confirm the identity of the scattered GFP-positive cells
in fz-2 MO-injected insulin:GFP embryos, fz-2 morphant
embryos were fixed at 24 hpf and analyzed for insulin
expression by in situ hybridization. At 24 hpf, wild-type
zebrafish embryos have a single islet consisting of 15–20
cells at the midline. In contrast, insulin-expressing cells in
fz-2 morphant embryos were scattered along the A-P axis
similar to the pattern of GFP-expressing cells in fz-2 MO-
injected transgenic embryos (Fig. 2F). The number of insu-
lin-positive cells in fz-2 morphants was not significantly
different from control embryos despite the abnormal islet
morphology, indicating that cell proliferation is not sig-
nificantly affected (average: 12 ± 2 cells in wild-type and
10 ± 2 cells in MO-injected, n = 25 for each group).
Injection of two different previously published MOs tar-
geting non-overlapping 5' regions of fz-2 mRNA generated
similar effects on insulin-expressing cell migration. Fur-
thermore, co-injection of two fz-2 MOs resulted in a syn-
ergistic increase in a percentage of embryos with scattered
insulin expression, suggesting a specific role of fz-2 in
proper islet formation (Fig. 2D). To assess whether scat-
tered  insulin  expression observed in fz-2 MO-injected
embryos was specific to the loss of fz-2 function, we also
injected a five-base mismatch fz-2 MO, which elicited no
effect on insulin-expressing cell migration (Fig 2E,G). To
test the specificity of the observed phenotype in fz-2 MO-
injected embryos further, we examined the ability of syn-
thetic fz-2 mRNA to reverse the observed defects in insulin-
positive cell migration. The injected synthetic fz-2 mRNA
contains a β-globin 5' leader sequence and does not con-
tain the fz-2 MO target-site sequence. Injection of fz-2 MO
resulted in 84% of the embryos (n = 77) with scattered
insulin expression (Fig. 2E,F). None of the fz-2 mRNA-
injected embryos (n = 81) displayed scattered insulin
expression (Fig. 2E,H). In contrast, co-injection of fz-2
MO and fz-2 mRNA resulted in a significantly lower fre-
quency of embryos (n = 112, p value = 0.001) with scat-
tered insulin expression compared with embryos injected
with fz-2 MO only (Fig. 2E,I). These results demonstrate
that the scattered insulin expression observed in fz-2 mor-
phant embryos is specific to the loss of fz-2 function.
Wnt-5 has a similar and specific role in islet formation
Because the Fz protein family can function as receptors of
Wnt proteins, we wanted to test if any known Wnt protein
is similarly required for insulin-positive cell migration.
Loss-of-function of three Wnts – wnt-5, -8, and -11 – are
each reported to cause developmental abnormalities
grossly similar to the ones observed in fz-2 morphants
[16,17]. Among these, wnt-5 exhibits the most similar
expression pattern to fz-2 during somitogenesis. Zebrafish
wnt-5 is weakly expressed in the posterior half of the som-
itic and lateral mesoderm and strongly in the tail bud dur-
ing somitogenesis [18]. Interestingly, double in situ
hybridization against wnt-5 and pdx-1 revealed that wnt-5
is expressed as a gradient of RNA from the posterior limit
of pdx-1 expression to the tail-bud at the 10-somite stage
when pdx-1 is first detected (Fig. 3A). However, we did not
detect wnt-5 in the GFP-positive cells isolated from insu-
lin:GFP transgenic zebrafish embryos indicating that wnt-
5 is not co-expressed with insulin (Fig. 2C, lane 10: com-
pare to wnt-5 band from GFP-negative cells in lane 5).
To identify a candidate Wnt ligand, we utilized injections
of MOs against wnt-5, -8, and -11 that effectively generate
mutant phenocopies [17,19]. We generated Wnt-5, -8,
and -11 morphants as described and analyzed insulin
expression by in situ hybridization at 24 hpf [17,19]. Islet
formation was normal in Wnt-8 and -11 morphant
embryos as analyzed for the expression of insulin, pdx-1,
glucagon and somatostatin (Fig. 3B–D, data not shown).
In contrast, analysis of insulin expression at 24 hpf of Wnt-
5 morphant embryos revealed scattered insulin expression
along the A-P axis, similar to the islet phenotype noted in
fz-2 morphant embryos (Fig. 3E).
To address the specificity of wnt-5 function in pancreatic
islet formation, we designed a second MO targeting the 3'
splice-site of exon 3. Injection of this MO resulted in effec-
tive skipping of exons 2 and 3, leading to a transcript that
is only about 200 bp in length (Fig. 3M). When we
injected this MO, embryos showed scattered insulin
expression similar to embryos injected with wnt-5 transla-
tion blocking MO (Fig. 3I), arguing that the zygotic func-
tion of wnt-5 is involved in insulin-positive cell migration.
In addition, injection of a five-base-mismatch wnt-5 MO
resulted in embryos with normal insulin expression (Fig.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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3F,I). Furthermore, the observed scattered insulin expres-
sion pattern in Wnt-5 morphant embryos was amelio-
rated by the addition of wnt-5* mRNA that encodes an
altered wnt5 open reading frame engineered with degener-
ate nucleotides in the region around the translation start
site to avoid targeting by the wnt-5 MO (see Methods).
When translation blocking wnt-5 MO was injected alone,
65% of embryos (n = 75) showed scattered insulin expres-
sion (Fig. 3E,I). Embryos injected with wnt-5* mRNA
alone resulted in 94% of embryos (n = 55) with normal
insulin expression (Fig. 3G,I). The percentage of embryos
with abnormal insulin expression decreased to 12% (n =
53, p value = 0.003) when embryos were co-injected with
wnt-5* mRNA (Fig. 3H,I).
We also analyzed insulin expression in two different pub-
lished wnt-5 mutant alleles (alleles of the mutant locus
pipetail; kind gifts of Dr. M. Hammerschmidt (pptti265) [20]
and Dr. N. Hopkins(ppthi1780b) [21]). In situ analysis using
the insulin marker did not detect any significant effect on
pancreas development in embryos homozygous for either
of the tested pipetail alleles (data not shown). Gross mor-
phological examination of embryos from either pipetail
allele demonstrated a significant inter-embryo variation
in manifestation of the pipetail  embryonic phenotype,
with the insertional allele (ppthi1780b) exhibiting an overall
more severe phenotype. The ppthi1780b allele showed phe-
notypes that were less extreme than the effects noted for
the wnt-5 morphants (Fig. 3J–L). To investigate further
whether the scattered insulin expression observed in WNT-
5 morphant embryos is specific to the loss of WNT-5 func-
tion, we tested to see if carriers of the ppthi1780b allele are
more sensitive to wnt-5 MO injection (Table 1). Injecting
2 ng of either translation-blocking or exon-intron junc-
tion targeting wnt-5 morpholinos in wild-type embryos
resulted in less than 5% of embryos with scattered insulin
expression. We injected the same low dose wnt-5 MOs
into embryos obtained from a cross between wnt-5
ppthi1780b allele carrier and wild-type adult fish. In this
batch of embryos, approximately 50% are expected to be
carriers of the ppthi1780b  allele. This study resulted in
approximately 50% of embryos exhibiting scattered insu-
lin expression (Table 1). Furthermore, genotyping of indi-
vidual embryo showed that 90% of embryos with
abnormal insulin expression were ppthi1780b carriers (n =
20) whereas 100% with normal insulin expression were
wild-type (n = 20), arguing that carriers of the ppthi1780b
allele are more sensitive to wnt-5 MO injection [see addi-
tional file 4]. These data argue that the observed wnt-5 MO
phenotype is specific to the targeting of the wnt-5 gene
and that zygotic wnt-5 function is required for normal
pancreatic islet formation.
WNT-5 and FZ-2 morphant embryos display a similar 
pancreatic developmental defect
To determine which step of pancreatic development is
perturbed, we analyzed the expression patterns of differ-
ent markers in fz-2  and  wnt-5  morphant embryos. We
examined early endodermal markers, mixer at 50% epi-
boly stage and sox-17 at 90% epiboly stage in fz-2 and wnt-
5 morphant embryos, and found that the expression of
mixer and sox-17 were normal in those embryos (Fig. 4A–
C, 4D–F). We also examined the anterior endoderm
marker, fox-A2, and the posterior endoderm marker, gata-
6, at 24 hpf in wild-type, fz-2  and  wnt-5  morphant
embryos. Expression of fox-A2 and gata-6 was normal in
both fz-2 and wnt-5 morphant embryos (Fig. 4G–I, 4J–L).
These results indicate that the abnormal insulin expression
observed in both fz-2 and wnt-5 morphant embryos is not
due to secondary defects because of abnormal endoderm
specification or migration.
At 24 hpf, somatostatin, a marker for mature pancreatic δ-
cells, was scattered similarly to insulin in both fz-2 and
wnt-5 morphant embryos (Fig. 5A–C). Glucagon, which is
expressed in pancreatic endocrine α-cells, was scattered
along the A-P axis but still expressed at the edge of the islet
in both fz-2  and  wnt-5  morphants (Fig. 5D–F). Other
endocrine pancreas markers, islet-1 and fspondin-2b, were
also scattered along the A-P axis (Fig. 5G–I, 5J–L).
At the 3dpf stage, insulin-positive cells remain scattered in
both wnt-5 and fz-2 morphants (Fig. 6A–C). Expression of
an exocrine pancreas marker, carboxypeptidase-A, and a
Table 1: Wnt-5 heterozygous embryos are more sensitive to wnt-5 MO injection in pancreatic islet formation.
WT WT X wnt-5/WT
trans-block wnt-5 MO exon-intron wnt-5 MO trans-block wnt-5 MO exon-intron wnt-5 MO
% of embryos with abnormal 
insulin expression
5 ± 2% 0% 46 ± 5% 52 ± 3%
total # of embryos N = 124 N = 113 N = 53 N = 57
2 ng of either wnt-5 translation-blocking or exon-intron junction targeting morpholinos were injected into either wild-type embryos or embryos 
generated from an outcross of a wnt-5 mutant carrier adult. In wild-type embryos, injection of either wnt-5 MO resulted in less than 5% of embryos 
with scattered insulin expression. However, injection of either wnt-5 MO resulted in about 50% of embryos with scattered insulin expression in 
embryos obtained from the wnt-5 mutant carrier outcross.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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Early endoderm markers are not affected in Wnt-5 and Fz-2 morphant embryos Figure 4
Early endoderm markers are not affected in Wnt-5 and Fz-2 morphant embryos. All pictures are dorsal views. (A, 
D, G, J, M) wild-type, (B, E, H, K, N) Fz-2 morphants, (C, F, I, L, O) Wnt-5 morphants. (A-C) mixer, 50% epiboly, (D-F) sox-17, 
90% epiboly, (G-I) fox-A3, 24 hpf, (J-L) anterior endoderm expression of fox-A3, arrow, pancreatic endoderm, 24 hpf, (M-O) 
gata-6, 24 hpf. Scale bar = 300 µm.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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liver marker, ceruloplasmin, was reduced in both fz-2 and
wnt-5  morphant embryos (Fig. 5D–I respectively). The
hollow spot indicating the position of the islet within the
exocrine pancreas was not observed in either wnt-5 or fz-2
morphants (Fig. 5D–F). This indicates that pancreatic
islets in wnt-5  and  fz-2  morphants are not completely
Wnt-5 and Fz-2 morphant embryos exhibit similar pancreatic islet defects at 24 hpf Figure 5
Wnt-5 and Fz-2 morphant embryos exhibit similar pancreatic islet defects at 24 hpf. In all panels, anterior is to the 
left and 24 hpf. .A-I, dorsal view; J-L, lateral view. (A, D, G, J) Wild-type embryos. (B, E, H, K) Fz-2 morphants. (C, F, I, L) Wnt-
5 morphants. In situ hybridization analysis of (A, B, C) somatostatin, (D, E, F) glucagon, notice a hollow spot in the middle of each 
patch, (G, H, I) islet-1, (J, K, L) fspondin-2b. Note scattered pancreatic cells in Fz-2 and Wnt-5 morphants.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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Wnt-5 and Fz-2 morphant embryos have other similar defects Figure 6
Wnt-5 and Fz-2 morphant embryos have other similar defects. In all panels, view is dorsal, anterior is to the left. (A-I, 
M-O) 3dpf, (J-L) 24 hpf stage. (A, D, G, J, M) Wild-type embryos. (B, E, H, K, N) Fz-2 morphants. (C, F, I, L, O) Wnt-5 mor-
phants. In situ hybridization analysis of (A-C) insulin, (D-F) carboxypeptidase A, notice the hollow spot indicating the position of 
the islet, (G-I) ceruloplasmin, (J-O) pdx-1, (M) arrow, pdx-1-staining in islet.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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Wnt-5 and fz-2 are in the same signaling pathway Figure 7
Wnt-5 and fz-2 are in the same signaling pathway. (A) Injection of either wnt-5 MO or fz-2 MO mix results in less than 
10% of embryos with scattered insulin expression. Co-injection of wnt-5 and fz-2 MOs results in 50% of embryos with defects. 
(B) Injection of either wnt-5 mRNA or fz-2 mRNA did not cause secondary axis in Xenopus embryos, whereas co-injection with 
both mRNAs resulted in 40% of embryos with secondary axis. Control injections of GFP mRNA alone or together with fz-2 
mRNA resulted in no embryos with secondary axis. (C-F) Xenopus embryos, tailbud stage, (C) wild-type, (D) wnt-5 and fz-2 
mRNA co-injected, black arrows-point to the primary and secondary hatching glands, (E) wnt-5 mRNA injected, (F) fz-2 mRNA 
injected.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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Wnt-5 acts genetically upstream of fz-2 Figure 8
Wnt-5 acts genetically upstream of fz-2. (A) Injection of wnt-5 MO alone results in 50% embryos with insulin cell defect. 
Injection of fz-2 mRNA results in 5% embryos with insulin cell defects. Co-injection of wnt-5 MO and fz-2 mRNA results in 
20% of embryos with abnormal insulin expression. In a control experiment, co-injection of wnt-5 MO and GFP mRNA results 
in 45% of embryos with defects. (B-D) Insulin expression as analyzed by in situ hybridization at 24 hpf, (B) wnt-5 MO injected, 
(C) fz-2 RNA injected, (D) wnt-5 MO- and fz-2 RNA-injected embryos. Note that fz-2 mRNA rescues insulin cell migration 
defect in wnt-5 morphants. (E) Same dose of wnt-5 mRNA that can rescue the insulin cell migration defects in wnt-5 morphants 
cannot rescue the defects in fz-2 morphants.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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embedded within exocrine tissue as found in wild-type
embryos. However, scattered insulin  expression is not
likely to be affected by the reduction of the exocrine pan-
creas, because the exocrine pancreas in zebrafish does not
develop until after the completion of insulin-positive cell
migration.
Our results suggest that fz-2 and wnt-5 have similar func-
tion in pancreatic islet development. Interestingly, exami-
nation of the transcription factor pdx-1 expression profile
revealed an unexpected phenotype in these embryos. Pdx-
1 is one of the earliest known markers for the entire pan-
creas and is important for both early pancreatic develop-
ment and adult β-cell function [22]. The area of pdx-1
expression was expanded in both fz-2  and  wnt-5  mor-
phants as analyzed by in situ hybridization at 24 hpf (Fig.
6J–L). At 3dpf, pdx-1 expression is restricted to the pancre-
atic islet, duct, and part of the intestine (Fig. 6M). Pdx-1-
expressing cells in fz-2  and  wnt-5  morphant embryos
remain scattered and do not coalesce into a single islet
until 3dpf (Fig. 6K,L) similar to insulin-expressing cells. In
addition, the area of pdx-1  expression in the intestine
becomes reduced in fz-2 and wnt-5 morphant embryos
compared to wild-type embryos at 3dpf (Fig. 6M–O). The
expanded pdx-1 expression at 24 hpf and misexpression at
3dpf in fz-2 and wnt-5 morphants requires further study
(see discussion).
Wnt-5 and fz-2 can genetically interact
We next determined if wnt-5 and fz-2 could interact genet-
ically. First, we co-injected low doses of wnt-5 and fz-2
MOs. If wnt-5 and fz-2 were in two independent signaling
pathways, co-injection of MOs against these genes would
result in an additive increase of embryos with abnormal
insulin  expression. In contrast, a synergistic increase of
embryos with abnormal insulin expression would indicate
that wnt-5 and fz-2 are either in the same signaling path-
way or in two pathways that can interact in the normal
insulin-positive cell migration process. Injection of a low
dose of wnt-5 MO resulted in 10% of embryos (n = 60)
with abnormal insulin expression. Injection of a low dose
of fz-2 MOs resulted in 12% of embryos (n = 48) with
abnormal insulin expression. When we co-injected wnt-5
MO and fz-2 MOs, 55% of embryos (n = 59) displayed
abnormal insulin expression, a synergistic increase in the
percentage of embryos with abnormal insulin expression
(Fig. 7A). This result suggests that wnt-5 and fz-2 can inter-
act genetically in the same signaling pathway during islet
formation.
To test a possible direct interaction between zebrafish wnt-
5 and fz-2 further, we used a Xenopus secondary axis induc-
tion assay [23]. In this system, a Fz-dependent induction
of the secondary axis in Xenopus has been shown to be the
result of direct receptor (Fz) activation by the Wnt ligand.
This effect can be mediated by Wnt ligands and Fz recep-
tors that normally function via either canonical or non-
canonical signaling processes. In this experiment, we
injected either wnt-5 mRNA or fz-2 mRNA into two ventral
blastomeres of 4-cell stage Xenopus  embryos. Injecting
zebrafish wnt-5 RNA or fz-2 RNA elicited a shortened and
mildly bent body at the tailbud stage without the induc-
tion of any secondary axes (Fig. 7B,E,F). When we co-
injected both RNAs in Xenopus embryos, more than 50%
of embryos showed a secondary axis at the tailbud stage
(Fig. 7B,D). This suggests that zebrafish Wnt-5 and Fz-2
proteins can interact functionally and signal when placed
in an appropriate cellular environment.
Fz-2 is epistatic to wnt-5
To determine if wnt-5 acts genetically upstream of fz-2, we
removed Wnt-5 protein by injecting wnt-5 MO and
assayed whether fz-2  mRNA can rescue the resulting
migration defects. When wnt-5 MO was injected alone,
56% of injected embryos (n = 42) showed scattered insulin
expression (Fig. 8A,B). Injection of fz-2 RNA alone did not
cause significant abnormalities in insulin expression (3%
of embryos, Fig. 8A,C). The percentage of embryos with
scattered insulin expression significantly decreased to 20%
(n = 50, p value = 0.019) when fz-2 RNA was co-injected
with wnt-5 MO (Fig. 8A,D). In a control experiment, co-
injection of wnt-5 MO and GFP RNA did not reduce the
percentage of embryos with abnormal insulin expression
(Fig. 8A).
In contrast, injection of wnt-5 RNA cannot ameliorate
defects in fz-2 morphant embryos (Fig. 8E). Injecting fz-2
MO resulted in 80% of embryos (n = 106) with scattered
insulin  expression. Injecting wnt-5 RNA caused 5% of
embryos (n = 42) with scattered insulin expression. Co-
injection of fz-2 MO and wnt-5 RNA resulted in 88% of
embryos (n = 84) with scattered insulin expression. These
results demonstrate that fz-2 RNA can rescue abnormal
islet morphology caused by the wnt-5 MO, whereas wnt-5
RNA cannot rescue abnormal islet morphology caused by
fz-2 MO, placing fz-2 genetically downstream of wnt-5 in
this process.
Wnt-5a knockout mice exhibit similar islet precursor cell 
migration defects and abnormal islet morphology
To test if the role of Wnt-5 signaling in pancreatic devel-
opment is conserved between different vertebrates, we
obtained mice heterozygous for a previously described
Wnt5a null allele [24]. Wild type and Wnt5a-/- embryos
were harvested at E16.5, E17.5 and E18.5 and examined
for defects in pancreatic development. Although Wnt5a-/-
embryos have defects in many structures, the size and
macroscopic morphology of the pancreas were normal
with a characteristic loose lobular appearance and normal
anatomical positioning: with the head of the pancreasBMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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located at the curve of the duodenum, the body associated
with the greater omentum at the ventro-posterior surface
of the stomach, and the narrower tail region pointed
towards the hilum of the spleen (data not shown). We
next performed immunohistochemical analysis of consec-
utive pancreatic sections with antibodies against insulin
and glucagon between E16.5, E 17.5 and E18.5. In both
wild type and mutant pancreata at E16.5, insulin-positive
cells were intermingled with glucagon-positive cells as
described previously [4] and did not have a typical mature
distribution with insulin cells located centrally and gluca-
gon cells located peripherally (Fig. 9A–D). At E17.5, insu-
lin-staining cells were becoming more compact and
glucagon-staining cells began to assume a peripheral dis-
tribution in both wild type and mutant mice (Fig. 9E–H).
Since this distinct cell architecture is not observed in wild
type mice before E17.5 [4,25], the appearance of the
peripheral distribution of glucagon-positive cells in the
mutant islets at E17.5 argues against maturational delay.
Similar pattern was observed in the islets at E18.5 with
insulin-producing β-cells in the center of the islet (Fig.
9I,K) and the glucagon-producing α-cells on the periphery
of the islet (Fig. 9J,L). However, when compared to com-
pact and round islets in wild type embryos, the mutant
islets were streaked along the pancreatic ducts (Fig. 10C),
similar to mice lacking EGF receptor [6]. This phenotype
is also very similar to that of zebrafish wnt-5 and fz-2 mor-
phants, in which glucagon positive cells are scattered
along the A-P axis while positioned at the periphery of
insulin-positive cells (Fig. 5E,F).
To examine whether defects in endocrine cell migration
during islet formation can cause streaked islets of Wnt5a-/
- embryos we used a previously described morphometry
method [6]. Since insulin-positive cells have to detach
and migrate away from the pancreatic ducts to form
mature islets, one of the measures of islet cell migration is
the degree to which insulin-positive cells remain in direct
contact with the ductal epithelium. To assess migration of
the endocrine cells in Wnt5a null embryos, we concen-
trated our analysis at E18.5, the latest time point at which
we can assess separation of insulin positive cells from the
ducts. Lethality at birth of Wnt5a knockout mice prohibits
later analysis of pancreas development in these mice.
When compared to wild-type embryos, the number of
islets separated from the ducts was greatly reduced in the
pancreata of Wnt5a-/-embryos (Fig. 10A). Only 15% of
Pancreatic islet development in Wnt5a-/- mouse embryos is not delayed Figure 9
Pancreatic islet development in Wnt5a-/- mouse embryos is not delayed. (A-D) E16.5, (E-H) E17.5, (I-L) E18.5, (A, C, 
E, G, I, K) insulin antibody staining, (B, D, F, H, J, L) glucagon antibody staining, (A, B, E, F, I, J) pancreas tissue from wild-type 
siblings, (C, D, G, H, K, L) pancreas tissue from Wnt5a-/- mouse embryos. Notice that glucagon staining is round and spherical 
at E16.5, but positioned at the periphery of insulin cells at E17.5 and E8.5.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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Wnt5a-/- islets remain in ductal proximity and have a streaked appearance at E18.5 Figure 10
Wnt5a-/- islets remain in ductal proximity and have a streaked appearance at E18.5. (A) In Wnt5a-/- embryos, most 
islets are associated with ducts. Both small and large β-cell aggregates are more frequently associated with pancreatic ducts in 
Wnt5a-/- embryos at E18.5 than in wild-type embryos. (B, C) Insulin antibody staining. (B) Round and compact islets in wild-type 
embryos. A normal pancreas consists of islets that are associated and separated from ducts. Arrows: pancreatic duct, asterisk: 
an islet separated from duct. (C) Streak-like, fragmented islets in Wnt5a-/- mutant embryos.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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small islets and 6% of larger islets were separated from the
ducts in the mutants, compared to 56% (P < 0.001) and
40% (P < 0.05) respectively in the wild type mice (Fig.
10B,C). Our results implicate that Wnt5a signaling is also
important in the insulin-positive cell migration process
during morphogenesis of the pancreas in higher verte-
brates.
Discussion
A hypothetical role of Wnt signaling in early pancreatic 
development
The function of a wnt-5/fz-2 pathway in insulin-positive
cell migration is most likely to provide the right environ-
ment and/or signals for insulin-positive cell migration dur-
ing islet formation. Our time-lapse analysis of fz-2 MO-
injected transgenic embryos shows that the insulin-posi-
tive cells still migrate, but their direction of migration is
random indicating these cells have lost key positional
information in the absence of the wnt5/fz2 signal (Fig. 1).
In addition, our cell sorting analysis shows that wnt-5
RNA is expressed in a posterior-anterior gradient, poten-
tially serving as a key step in establishing the positional
information required by these migrating cells. Analysis of
the receptor, fz-2, however, reveals a further complexity.
Fz-2 RNA is detected in the cells immediately adjacent to
the mis-migrating insulin-positive cells, suggesting that the
function of wnt-5/fz-2 pathway activation in islet cell for-
mation is a cell-non-autonomous and/or cell-cell instruc-
tive function in the transmission of this positional
information (Fig. 2B). Interestingly, non-autonomous fz-
mediated signaling has been observed during Drosophila
development [51], but this process of information
exchange does not require any cell migration movements
or, apparently, any wnt  ligand [52]. Further study is
required to determine how the wnt-5/fz-2 signaling pro-
duces the right environment that allows normal insulin-
positive cell migration during islet formation.
The activation of Wnt-5 signaling can change intracellular
Ca2+ concentration [26]. One hypothesized function of
the Wnt/Ca2+ pathway is to antagonize a second and
simultaneously active Wnt/β-catenin pathway [27,28].
Wnt/β-catenin signaling is known to specify cell fate
directly [2]. For example, reduction of maternal and
zygotic wnt-5 activity using genetic approaches results in
hyperdorsalized embryos [27]. Further investigation is
required to determine whether wnt-5/fz-2 signaling pro-
vides the right environment and/or signals for normal
insulin-positive cell migration by antagonizing the Wnt/
β-catenin pathway or by another novel mechanism.
We observed an altered expression pattern of pdx-1 tran-
script in both wnt-5 and fz-2 morphant embryos. In our
time-lapse imaging analysis, however, we observed that
the initial specification of insulin-expressing cells was nor-
mal, and we observed no ectopic insulin-positive cells in
spite of expanded pdx-1 expression in fz-2 or wnt-5 mor-
phant embryos. Furthermore, the number of insulin-
expressing cells is not increased in either fz-2 or wnt-5
morphant embryos even though these embryos displayed
two or more insulin expression domains, sometimes with
single cell patches, as observed in our time-lapse imaging
analyses. These data suggest that the scattered insulin-
expression is not due to ectopic islet formation. Future
work will be required to detail the role (if any) for this
expanded pdx-1 expression in abnormal insulin-positive
cell migration.
A role for Wnt-5 in pancreatic islet formation is conserved 
between mammals and teleosts
Vertebrate pancreatic development is described here in
one of its simplest forms in zebrafish (represented by a
single islet at 24 hours of development) and by a more
complex vertebrate system in mouse. Certain processes of
pancreatic islet formation in zebrafish and mouse appear
to be incongruent. For example, sonic hedgehog (shh),
which is expressed in the entire endoderm except for the
pancreatic endoderm, was shown to be a negative regula-
tor of the adoption of pancreatic endoderm fate in mice
[29,30]. In zebrafish, however, shh and other hh proteins
are not expressed in the endoderm [31]. In addition,
ectopic expression of shh induces a pancreatic cell fate
rather than represses it, a result opposite to what was
observed in mammalian models [31,32]. Despite these
differences, the initial specification of insulin-expressing
cells occurs before an islet is formed in both animals, and
these insulin-positive cells migrate and form an islet at a
distance from where they are initially specified. Even
though a comparable structure to a duct does not exist in
zebrafish at the stage when islet formation occurs, previ-
ous studies in mouse and our time-lapse imaging analysis
show that this migration process of islet formation is sim-
ilarly required to form normal islets in both mouse and
zebrafish. The final disorganized islet phenotypes were
observed as a result of abnormal migration of insulin-pos-
itive cells in both zebrafish and mouse embryos with dis-
rupted Wnt5 signaling. These results argue that Wnt5
signaling is required in pancreatic islet formation of both
mouse and zebrafish, a role most likely shared through-
out the vertebrate lineage.
Fz-2 is a putative receptor for Wnt-5 in pancreatic islet 
formation
Our results suggest that wnt-5 is upstream of fz-2 in the
same genetic pathway and show that Fz-2 functions as a
receptor for Wnt-5 when placed in the right environment,
as assayed using the Xenopus secondary axis assay system.
In mouse, fz-2 and wnt-5 transcripts are expressed at the
highest level among different wnts and fzs in the develop-
ing mouse pancreas, providing evidence that wnt-5 and fz-BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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2 are expressed at the right place and time to be involved
in islet formation as a functional ligand and receptor pair
[3]. In zebrafish, early fz-2 expression is observed during
somitogenesis. This expression pattern coincides with the
timing and location of insulin cell migration, indicating
that fz-2 is expressed at the right time and place to be
involved in normal insulin-positive cell migration in
zebrafish. Although wnt-5, wnt-11 and wnt-8 are expressed
at the 14-somite stage, only wnt-5 and wnt-11 transcripts
are detected at the location close to the presumptive pan-
creatic endoderm marked by pdx-1. wnt-5 is not expressed
in the endoderm, but it is expressed in adjacent mesoderm
close to the posterior boundary of early pdx-1 expression.
wnt-5 proteins may be secreted from the mesoderm and
signal to adjacent endoderm. Furthermore, our data show
that wnt-11 morphant embryos have a normal pancreatic
islet formation, whereas wnt-5 morphant embryos have
similar pancreatic islet formation defects as fz-2 morphant
embryos placing wnt-5 as the best candidate ligand for fz-
2 in pancreatic islet formation.
Wnt-5 signaling has a specific role in pancreatic islet 
formation that is separable from other Wnt signaling 
events in embryogenesis
In embryos with defects in body axis elongation, some sig-
nificant secondary effects on other organizing centers may
occur. For example, zebrafish wnt-5 [20], wnt-8 [19], wnt-
11 [33] and knypek [34] morphant or mutant embryos dis-
play undulating notochord, reduced body length and a
number of other less apparent abnormalities. These
defects could conceivably result in abnormal pancreatic
islet formation. However, wnt-8  and  wnt-11  morphant
embryos display normal islet formation despite body
elongation defects. This supports a specific role of Wnt-5
signaling in pancreatic islet formation that is not second-
ary to body elongation defects. In addition, injection of
wnt-5 and fz-2 mRNA ameliorates the pancreatic islet for-
mation defects in wnt-5  and  fz-2  morphant embryos,
respectively, but not the body elongation defects under
the same conditions. These results strongly suggest that
pancreatic islet formation is at least partially independent
of the body axis elongation process. In addition, the ini-
tial specification of insulin-positive cells occurs at the right
place and time in zebrafish embryos. The congregation of
insulin-positive cells occurs normally, and glucagon cells
surround the insulin-positive cells in mouse Wnt5a-/-
knockout embryos and wnt-5 and fz-2 morphant zebrafish
embryos. Finally, the development of a grossly normal
pancreas in Wnt5a-/- mouse knockout embryos, and the
subsequent defect in islet formation, emphasizes the pos-
sible function of Wnt5 signaling during later stages of
pancreatic islet morphogenesis.
Conclusion
We examined a role of Wnt-5 signaling in pancreatic islet
morphogenesis in zebrafish and mouse embryos. Time-
lapse imaging of insulin-positive cells using transgenic
zebrafish embryos revealed that gradual formation of a
single islet in zebrafish is a result of an active cell migra-
tion process. Here we demonstrate that wnt-5 and fz-2
morphant embryos display defects in insulin-positive cell
migration providing evidence for a role of Wnt5 signaling
in this process. Comparative analyses of pancreatic tissue
from Wnt5a knockout mice show that endocrine cells are
specified normally within the primitive pancreatic epithe-
lium. However, these insulin-positive cells fail to migrate
from the ducts and form fragmented islets around ducts
with glucagon-expressing cells positioned at the periphery.
This argues that Wnt5a is required for insulin-positive cell
migration, but not local organization within a forming
islet in both mouse and zebrafish. Taken together, these
results provide evidence that wnt-5/fz-2 signaling is
required for the migration of insulin-positive cells during
pancreatic development, and that this function is con-
served. This study will help us to understand better the
role of Wnt signaling during vertebrate pancreatic devel-
opment and broaden our understanding of a role of Wnt
signaling in pancreatic diseases. Wnt signaling pathways
have been implicated in the pathogenesis of cancer [35],
regulation of adipogenesis and insulin secretion [36,37].
Wnt5b, for example, has recently been identified as a can-
didate gene for conferring susceptibility to type 2 diabetes
[38]. Wnt5a may inhibit the canonical Wnt pathway by
promoting β-catenin degradation [28]. Interestingly, dys-
regulation of β-catenin has been identified in various
forms of malignancy, including pancreatic tumors [39].
Our study reports a new and conserved role of Wnt-5 sig-
naling in pancreatic islet formation and provides an
example of how Wnt signaling functions in organogene-
sis.
Methods
Synthesis and microinjection of mRNAs
Wnt-5 ORF cDNA was amplified from a gastrula stage
library and subcloned into pT3TS [40]. The modified wnt-
5* construct was made using a degenerate 5' primer
designed to have a mismatch with the published wnt-5
MO (5'-ATG GAC GTA CGT ATG AAT CAG GGT CAC CTA
CTT CTG GCA G-3'). The degenerate PCR fragment was
subsequently subcloned into pT3TS vector at SpeI site. To
synthesize sense wnt-5 mRNA, the wnt-5-T3TS construct
was digested with XbaI and transcribed using T3 mMes-
sage mMachine kit (Ambion). Modified wnt-5 mRNA (4
pg) was injected for the wnt-5 rescue experiment.
Fz-2 ORF cDNA was amplified from the gastrula library
and subcloned into pT3TS. Fz-2 construct was cut with
XbaI  and transcribed with T3 mMessage mMachine kitBMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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(Ambion). For Xenopus assay, 500 pg of fz-2 mRNA was
injected into two ventral blastomeres of 4-cell stage Xeno-
pus embryos. For the fz-2 MO specificity experiment and
wnt-5 and fz-2 epistasis experiment, 25 pg of fz-2 mRNA
was injected.
Microinjection of MOs
We injected 2.5 ng of the previously described wnt-5 MO
for the wnt-5 and fz-2 genetic interaction experiment and
8 ng of the same wnt-5 MO for all other experiments [17].
We also used 5 ng of wnt-5 MO (5'-TGTTTATTTCCTCAC-
CATTCTTCCG-3') targeting the 3' end of the exon-intron
junction of exon 3. As a control, 8 ng of a five-base mis-
match wnt-5 MO (5'-GTCGTTGCTTCTTTCACACTTC-
CAT-3') was injected.
For the analysis of different pancreatic markers, we
injected 5 ng of fz-2 MO mix (2.5 ng of fz MO-1 and 2.5
ng of MO-2) as described [14]. As a control, 5 ng of a five-
base mismatch fz-2 morpholino (5'-CCTCCATAGTCAC-
GATAAGTTCGGC-3') was injected. For the wnt-5/fz-2
genetic interaction experiment, we injected 2 ng of fz-2
MO mix (1 ng of fz-2 MO-1 and 1 ng of fz-2 MO-2). For
the FZ-2 morphant rescue experiment, we used 2 ng fz-2
MO-1.
We injected 2–4 ng of the previously described wnt-11
MO to generate WNT-11 morphant embryos [17]. Two
specific MOs targeting WNT-8 have been previously
described [16,19]. Embryos were injected with 1–8 ng of
wnt-8 MO1, 1–5 ng of wnt-8 MO2 or 2 ng wnt-8 MO mix
(1 ng of wnt-8 MO1 and 1 ng of wnt-8 MO2).
All three groups of embryos were allowed to develop for
24 hours and subsequently analyzed for pancreatic mark-
ers. Microinjections were performed at the one-cell stage
as described [40].
In situ hybridization
Single color in situ hybridization was performed as
described [41]. Double color in situ hybridization was per-
formed as described [42]. Fz-2 antisense riboprobe was
synthesized as described [14]. To synthesize wnt-5 probe,
wnt-5 ORF cDNA was sub-cloned into 4-TOPO vector
(Invitrogen) and subsequently cut with NsiI  and tran-
scribed with T3 RNA polymerase. The following probes
were used: pdx-1, insulin [43], glucagon, somatostatin [11],
islet-1 [44], fspondin-2b [45], sox-17 [46], fox-A2 [47], gata-
6 [48], mixer [35], ceruloplasmin [49] and carboxypeptidase
A [32]. The mixer probe construct was synthesized by sub-
cloning a 1 kb PCR fragment into the 4-TOPO vector. To
synthesize the probe, DNA was cut with NotI and tran-
scribed with T3. The fox-A2 probe construct was synthe-
sized by sub-cloning a 1 kb PCR fragment of fox-A2 into
the 4-TOPO vector. To synthesize the probe, DNA was
digested with NotI and transcribed with T3. The carbox-
ypeptidase A probe construct was synthesized by subclon-
ing a 500 bp PCR fragment into the TOPO vector. To
synthesize the probe, DNA was digested with NotI and
transcribed with T3. The gata-6 probe was synthesized by
digesting an EST clone obtained from ZFIN (cb 603) with
Sal1 and transcribing with SP6.
RNA microinjection into Xenopus embryos
Wild-type zebrafish wnt-5 mRNA (250 pg) and 500 ng of
zebrafish fz-2 RNA was injected alone or in conjunction
into the two ventral blastomeres of the 4-cell stage Xenopus
embryos (total of 500 pg wnt-5 RNA and 1 ng of fz-2
RNA). As a control, 500 ng of GFP RNA was injected alone
or together with fz-2 RNA. The injected embryos were
scored for double axes at the tailbud stage. Injections were
performed as described [40].
Time-lapse imaging
The 14 somite stage embryos were dechorionated and
embedded in 0.8% low melting point agarose with 0.05%
3-aminobenzoic acid ethyl ester in a home made holding
chamber. To prevent drying, the embedded embryo was
covered with mineral oil and then overlaid with a cover
slip. The images were captured every minute for 4–6 hours
using a digital camera (Hamamastu, C4742-95) attached
to a compound microscope with automated base (Zeiss)
and OpenLab program.
Cell dissociation and FACS analysis
Insulin:GFP transgenic zebrafish embryos at the 20 som
stage were dechorionated and homogenized in cold 1X
Danieau/ 15% fetal bovine serum (FBS) solution using a
tissue grinder. Homogenized embryos were washed twice
with cold 1X Dan/15% FBS and incubated in 1X Danieau/
15% FBS containing 10 mg/ml collagenase/dispase
(Roche, #10269638001), 10 mg/ml trypsin and 10 unit/
ml DNase 1 at 30°C for one hour with gentle agitation.
Dissociated cells were subsequently washed twice, filtered
through a cell strainer and finally suspended in 1X Dan/
15% FBS supplemented with 1 µg/ml DAPI (Roche,
#10236276001: to label dead cells and other debris).
Cells were sorted using a cell sorter (BD science), collected
in 100% FBS, and processed for subsequent total RNA iso-
lation using an RNAqueous-4PCR kit (Ambion, #1914).
For subsequent RT-PCR, cDNA was synthesized using
Powerscript Reverse Transcriptase (BD science, #8460).
The following primers were used. EF1-a: TCACCCT-
GGGAGTGAAACAGC, ACTTGCAGGCGATGTGAGCAG,
insulin: CCATATCCACCATTCCTCG, CGGAGAGCAT-
TAAGGCCTG, fz-2 set#1: ATGCAGGCGAGTGGAAGTG,
CTTATAGCTGAGGTAGGCTG, fz-2 set#2: TGGCGTCT-
GGACAGCATC, TCCTGGTCTGTGAAGAACAT, wnt-5:
ATGGATGTGAGAATGAACCAA, CTACTT-
GCACACAAACTGGTC.BMC Biology 2005, 3:23 http://www.biomedcentral.com/1741-7007/3/23
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Genotyping of zebrafish ppthi1780b allele
Zebrafish embryos injected with low dose exon-intron
blocking wnt-5 MO were raised up to 3 days. The heads of
these embryos were excised and frozen in -80°C for fur-
ther genotyping and the bodies were further processed for
insulin expression using in situ hybridization. After the
insulin expression pattern analysis, genomic DNA of 20
embryos with normal and abnormal insulin expression
pattern was isolated from the frozen head tissue and gen-
otyped as described [21].
Genotyping of mice
Genomic DNA was isolated from tails or yolk sacs by
standard methods [50] and amplified by PCR using the
following primers: W1 (5'-GAC TTC CTG GTG AGG GTG
CGT G-3'), W2 (5'-GGA GAA TGG GCA CAC AGA ATC
AAC-3'), and W3 (5'-GGG AGC CGG TTG GCG CTA CCG
GTG G-3'). The PCR settings were: 30 cycles, 94°C for 30
seconds, 65°C for 30 seconds, 72°C for 1 minute. A 360
bp band identified a wild-type allele, while a 200 bp band
identified the mutant allele.
Histological analysis
Embryos used in this study were obtained by intercrossing
Wnt5+/- mice [24]. Plug date was considered E0.5. The
wild type (N = 5) and Wnt5a-/- (N = 8) embryos were har-
vested between E16.5-E18.5. The pancreatic tissue was
dissected from the embryos, fixed in 4% paraformalde-
hyde, washed in PBS, dehydrated through alcohols,
embedded in paraffin and cut into 7–9 µm thick sections.
Immunohistochemistry
Immunohistostaining to detect the islets of Langerhans
was done using commercially available mouse mono-
clonal anti-insulin antibodies (SIGMA I-2018) for β-cells,
and anti-glucagon (G-2654) antibodies for α-cells as pre-
viously described [51]. The sections were rehydrated,
incubated in methanol containing 1% H2O2, and washed
in PBS. The sections were then incubated with primary
antibodies (concentration 1:500) at 4°C overnight. After
washing the slides in PBS, the sections were incubated
with biotinylated mouse IgG at 1:500 (Vector Laborato-
ries) at room temperature for one hour. In order to detect
the staining, the slides were incubated in Vectastain rea-
gent for 30 minutes, followed by the diaminobenzidine
detection method. The slides were then background
stained by dipping them in hematoxylin 2 for 5 seconds,
washed and cover slipped.
Morphometry
We defined small islets as insulin-positive aggregates 25–
70 µm in diameter and large islets as aggregates greater
than 70 µm in diameter. A total of 31 islets from 3 wild
type embryos and 56 islets from 5 Wnt5a-/- embryos were
counted and classified as being either associated with duc-
tal tissue or not associated. Islets were defined as associ-
ated with ductal tissue if insulin-positive cells were in
direct contact with duct epithelium [6]. 16 WT and 38
knockout islets 20–70 µm in size, and 15 WT and 18
knockout islets over 70 µm in size, were counted and clas-
sified.
Statistical analysis
The statistical significance between the groups was deter-
mined by the Student's T-test for zebrafish experiments
and by a Chi-Square test for the mouse experiment.
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(QuickTime format) WT movie. Figure 1C–H panels were taken from 
this movie at the indicated time points. GFP-positive cells are first 
observed around the 14 somite stage as bilateral patches in insulin:GFP 
transgenic embryos. These cells divide and actively migrate to the poste-
rior. The net movement towards the midline is an indirect result of con-
vergent-extension since active migration towards the midline is not 
observed. By the 24 hpf stage, GFP-positive cells are coalesced into a single 
islet in the posterior and midline relative to the starting position.




Two color time-lapse imaging shows that GFP-positive cells migrate 
relative to the neighboring cells. (A) GFP-positive cells are first visible 
posterior to rhodamine-labeled cells as bilateral lows of cells. (B-G) GFP-
positive cells migrate posteriorly and medially, whereas rhodamine-labeled 
cells do not change their relative position. (H) At 24 hpf, all GFP-positive 
cells coalesced into a single islet, but the rhodamine-labeled cells remain 
separated at their original position. Arrows: rhodamine-labeled cells; t: 
time (minutes).
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Genotyping of embryos with normal and abnormal insulin expression. 
(A) 90% of embryos with abnormal insulin expression are carriers of 
ppthi1780b. Lane 4 and lane 15 represent wild-type embryos with abnor-
mal insulin expression. (B) Control PCR for exon 1 of wnt-5, N = water 
only control. (C) None of the embryos with normal insulin expression are 
carriers of ppthi1780b. (D) Control PCR for exon 1 of wnt-5, N = water 
only control.
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